Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Minerva Neurosciences
Biotech
Minerva's schizophrenia drug rejected by FDA for 2nd time
Minerva's schizophrenia drug has been rejected by the FDA, which said the studies to support approval did not establish evidence of effectiveness.
Annalee Armstrong
Feb 27, 2024 9:34am
Minerva Neurosciences shares crushed under depression flop
Dec 19, 2019 7:43am
Minerva's sleep drug bests Ambien, placebo in dose-finding study
Jun 24, 2019 2:51pm